1. The multi-talented podocyte. Fogo AB (2009) Nephrol Dial Transplant 24(11): 3269-70
    › Primary publication · 19720662 (PubMed)
  2. Renal dysfunction potentiates foam cell formation by repressing ABCA1. Zuo Y, Yancey P, Castro I, Khan WN, Khan W, Motojima M, Ichikawa I, Fogo AB, Linton MF, Fazio S, Kon V (2009) Arterioscler Thromb Vasc Biol 29(9): 1277-82
    › Primary publication · 19667109 (PubMed) · PMC2748735 (PubMed Central)
  3. Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study Group. Joy MS, Gipson DS, Dike M, Powell L, Thompson A, Vento S, Eddy A, Fogo AB, Kopp JB, Cattran D, Trachtman H (2009) Clin J Am Soc Nephrol 4(1): 39-47
    › Primary publication · 19073787 (PubMed) · PMC2615712 (PubMed Central)
  4. PAI-1 and kidney fibrosis. Ma LJ, Fogo AB (2009) Front Biosci (Landmark Ed) : 2028-41
    › Primary publication · 19273183 (PubMed) · PMC4848749 (PubMed Central)
  5. Obesity-related focal and segmental glomerulosclerosis: normalization of proteinuria in an adolescent after bariatric surgery. Fowler SM, Kon V, Ma L, Richards WO, Fogo AB, Hunley TE (2009) Pediatr Nephrol 24(4): 851-5
    › Primary publication · 18941798 (PubMed)
  6. Dystroglycan in the diagnosis of FSGS. Giannico G, Yang H, Neilson EG, Fogo AB (2009) Clin J Am Soc Nephrol 4(11): 1747-53
    › Primary publication · 19808230 (PubMed) · PMC2774958 (PubMed Central)
  7. Concurrent and discrete clinicopathological presentations of Wegener granulomatosis and anti-glomerular basement membrane disease. Clyne S, Frederick C, Arndt F, Lewis J, Fogo AB (2009) Am J Kidney Dis 54(6): 1116-20
    › Primary publication · 19577351 (PubMed)
  8. Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt. Lea WB, Kwak ES, Luther JM, Fowler SM, Wang Z, Ma J, Fogo AB, Brown NJ (2009) Kidney Int 75(9): 936-44
    › Primary publication · 19225557 (PubMed) · PMC2770712 (PubMed Central)
  9. Thrombotic microangiopathy and other glomerular disorders in the HIV-infected patient. Fine DM, Fogo AB, Alpers CE (2008) Semin Nephrol 28(6): 545-55
    › Primary publication · 19013325 (PubMed)
  10. Potential for peroxisome proliferator-activated receptor-gamma agonists in progression: beyond metabolism. Fogo AB (2008) Curr Opin Nephrol Hypertens 17(3): 282-5
    › Primary publication · 18408479 (PubMed)